IRIS PubliCatt

Bellesi, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.272
NA - Nord America 2.203
AS - Asia 448
AF - Africa 27
SA - Sud America 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.964
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.176
DE - Germania 799
SE - Svezia 440
CN - Cina 292
IT - Italia 292
PL - Polonia 178
FR - Francia 137
UA - Ucraina 116
GB - Regno Unito 112
IE - Irlanda 105
IN - India 55
FI - Finlandia 36
CA - Canada 27
CI - Costa d'Avorio 21
TW - Taiwan 21
TR - Turchia 18
BE - Belgio 12
JP - Giappone 12
IR - Iran 11
HK - Hong Kong 8
ES - Italia 7
BR - Brasile 5
KR - Corea 5
MY - Malesia 5
PT - Portogallo 5
AT - Austria 4
AU - Australia 4
CH - Svizzera 4
GR - Grecia 4
IL - Israele 4
RO - Romania 4
VN - Vietnam 4
CL - Cile 3
NO - Norvegia 3
RU - Federazione Russa 3
SG - Singapore 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
NL - Olanda 2
RS - Serbia 2
TH - Thailandia 2
BG - Bulgaria 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 4.964
Salva come PNG Salva come JPEG
Città #
Chandler 482
Ashburn 184
Warsaw 178
Fairfield 116
Dublin 104
Jacksonville 90
San Mateo 81
Houston 76
New York 71
Nanjing 64
Wilmington 64
Beijing 62
Dearborn 60
Ann Arbor 58
Rome 53
Woodbridge 53
Nürnberg 50
Seattle 49
Marseille 46
Boston 38
Bremen 37
Cattolica 37
Milan 35
Princeton 34
Lancaster 31
Nanchang 29
Redwood City 24
Abidjan 21
Cambridge 20
Lawrence 20
Chicago 18
Hangzhou 17
Leawood 16
Guangzhou 13
London 13
Los Angeles 13
Fremont 12
Helsinki 12
Tianjin 12
Boardman 11
Hefei 11
Izmir 11
Munich 11
Brussels 10
Changsha 10
Norwalk 10
Florence 9
Kunming 9
Auburn Hills 8
Hebei 8
Pune 8
Redmond 8
Shanghai 8
Augusta 7
San Diego 7
Washington 7
Zhengzhou 7
Enterprise 6
Hong Kong 6
Jiaxing 6
Kish 6
Mountain View 6
Phoenix 6
Romainville 6
Shenyang 6
Andover 5
Hyderabad 5
Philadelphia 5
San Francisco 5
Toronto 5
University Park 5
Arezzo 4
Bologna 4
Falls Church 4
Kocaeli 4
Kuala Lumpur 4
Seoul 4
São Paulo 4
Busto Arsizio 3
Changchun 3
Dong Ket 3
Lanzhou 3
Mumbai 3
Quzhou 3
Tokyo 3
Asti 2
Baltimore 2
Basel 2
Ben Arous 2
Berlin 2
Campobasso 2
Central 2
Chatsworth 2
Chengdu 2
Chester Springs 2
Costa Mesa 2
Dubai 2
Frankfurt Am Main 2
Fukuchiyama 2
Fuzhou 2
Totale 2.710
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 346
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 277
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 257
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 195
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 163
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 159
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 158
Correlation between paraproteinaemia and viral reactivation after allo-SCT 131
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 129
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 128
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 127
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 121
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 119
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 119
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 114
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 97
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 97
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 93
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 93
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 90
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 89
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 89
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 88
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 83
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 80
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 79
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 75
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 71
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 71
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 68
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 68
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 63
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 62
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 62
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 61
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 60
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 59
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 59
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results 58
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 58
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 52
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 52
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 52
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 51
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 49
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 45
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 43
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 42
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 38
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 36
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 36
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 35
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 35
External validation of the accuracy of 'CLLflow score' 22
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 21
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 21
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 19
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 6
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 5
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 4
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 3
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 3
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 2
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 1
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 1
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 1
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 1
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 1
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 1
Totale 5.094
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019109 0 0 0 0 0 0 0 0 0 0 69 40
2019/2020867 108 71 57 80 70 84 70 51 68 69 96 43
2020/2021611 33 44 36 50 71 53 41 26 44 42 143 28
2021/2022619 49 32 7 14 33 20 18 83 33 64 116 150
2022/20231.381 203 193 87 232 93 138 95 96 139 43 45 17
2023/2024558 33 181 28 41 26 100 54 54 10 29 2 0
Totale 5.094